换一批
换一批Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
第一作者：
Bryan P,Schneider
第一单位：
Indiana University School of Medicine, Indianapolis, IN, USA. bpschnei@iupui.edu
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);基因型(Genotype);单倍型(Haplotypes);人类(Humans);高血压(Hypertension);紫杉酚(Paclitaxel);多态性, 单核苷酸(Polymorphism, Single Nucleotide);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);统计学, 非参数(Statistics, Nonparametric);存活率(Survival Rate);血管内皮生长因子A(Vascular Endothelial Growth Factor A);血管内皮生长因子受体2(Vascular Endothelial Growth Factor Receptor-2)
DOI
10.1200/JCO.2008.16.1612
PMID
18824714
发布时间
2024-03-14
- 浏览130
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
